Many testing methods for COVID-19 rely on nucleic acid testing, making it difficult to determine duration and timeline of infection status. With the Biolidics IgG/IgM Antibody Detection Kit, COVID-19 cases can be confirmed at earlier and with greater accuracy about stage of infection.
Test fast, test early, test smart.
The human body produces IgM and IgG antibodies during viral infections, where IgM antibodies are generated in the initial response and IgG antibodies produced around day 14 after infection and beyond. Monitoring IgM and IgG antibodies as co-indicators can provide informative insight on a patient’s current stage of infection and previous infection exposures. The Biolidics IgG/IgM Antibody Detection Kit utilizes colloidal gold-labeled antigens to bind to each sample’s antibodies and generate readable lines with high accuracy.